Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)

被引：0
作者：
Yiqun Chen
Zhenguo Qiu
Anmmd Kamruzzaman
Tom Snodgrass
Andrew Scarfe
Heather E. Bryant
机构：
[1] Cancer Institute New South Wales,Cancer Information and Registries Division
[2] Alberta Cancer Board,Division of Population Health and Information
[3] Alberta Cancer Board,Cross Cancer Institute
[4] Canadian Partnership Against Cancer,undefined
来源：
Supportive Care in Cancer | 2010年 / 18卷
关键词：
Metastatic colorectal cancer; Chemotherapy; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：217 / 224
页数：7
相关论文
共 50 条
[31]   Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer [J].
Yang, Qiong ;
Yin, Chenxi ;
Liao, Fangxin ;
Huang, Yuanyuan ;
He, Wenzhuo ;
Jiang, Chang ;
Guo, Guifang ;
Zhang, Bei ;
Xia, Liangping .
ONCOTARGETS AND THERAPY, 2015, 8 :2407-2413
[32]   Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent [J].
Wong, Shu Fen ;
Wong, Hui Li ;
Field, Kathryn M. ;
Kosmider, Suzanne ;
Tie, Jeanne ;
Wong, Rachel ;
Tacey, Mark ;
Shapiro, Jeremy ;
Nott, Louise ;
Richardson, Gary ;
Cooray, Prasad ;
Jones, Ian ;
Croxford, Matthew ;
Gibbs, Peter .
CLINICAL COLORECTAL CANCER, 2016, 15 (03) :E125-E132
[33]   Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in FRESCO trial [J].
Qin, Shukui ;
Li, Jin ;
Bai, Yuxian ;
Deng, Yanhong ;
Yang, Lei ;
Xu, Rui-Hua ;
Zhong, Haijun ;
Chen, Zhendong ;
Pan, Hongming ;
Guo, Weijian ;
Shu, Yongqian ;
Xu, Jianming ;
Peng, Cike ;
Chen, Yun ;
Li, Hongyan ;
Wang, Ning ;
Guo, Xiaojun ;
Peng, Mengye ;
Fan, Songhua ;
Shen, Lin .
FUTURE ONCOLOGY, 2021, 17 (15) :1923-1931
[34]   HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer [J].
Khelwatty, Said A. ;
Puvanenthiran, Soozana ;
Essapen, Sharadah ;
Bagwan, Izhar ;
Seddon, Alan M. ;
Modjtahedi, Helmout .
CANCERS, 2021, 13 (04) :1-15
[35]   Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer [J].
Ailawadhi, S ;
Sunga, A ;
Rajput, A ;
Yang, GY ;
Smith, J ;
Fakih, M .
ONCOLOGY, 2006, 70 (01) :49-53
[36]   Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancer [J].
Diaz, Roberto ;
Aparicio, Jorge ;
Molina, Jorge ;
Palomar, Laura ;
Gimenez, Alejandra ;
Ponce, Jose ;
Segura, Angel ;
Gomez-Codina, Jose .
MEDICAL ONCOLOGY, 2006, 23 (03) :347-357
[37]   Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancer [J].
Zhou, Yuwen ;
Zhang, Jing ;
Pu, Dan ;
Bi, Feng ;
Chen, Ye ;
Liu, Jiyan ;
Li, Qiu ;
Gou, Hongfeng ;
Wu, Bing ;
Qiu, Meng .
ANTI-CANCER DRUGS, 2019, 30 (02) :195-200
[38]   Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy [J].
Cybulska-Stopa, Bozena ;
Lugowska, Iwona ;
Wisniowski, Rafal ;
Domagala-Haduch, Malgorzata ;
Rajczykowski, Marcin ;
Piejko, Karolina ;
Bar-Letkiewicz, Ilona ;
Suwinski, Rafal ;
Regulski, Krzysztof ;
Mackiewicz, Jacek .
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (01) :34-41
[39]   Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer [J].
Cicero, Giuseppe ;
De Luca, Rossella ;
Dieli, Francesco .
ONCOTARGETS AND THERAPY, 2018, 11 :3059-3063
[40]   Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy [J].
Wang, Zhiming ;
Liang, Li ;
Yu, Yiyi ;
Wang, Yan ;
Zhuang, Rongyuan ;
Chen, Yong ;
Cui, Yuehong ;
Zhou, Yuhong ;
Liu, Tianshu .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (03) :1239-1246
12345